Paul Hartmann Manufacturingsp. z o.o.
Manufacture of medical and dental instruments and supplies
Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Bank accounts
Registered as a VAT taxpayer on 2021-05-13. Active
44 1600 1462 1859 4239 1000 0016- 61 1600 1462 1859 4239 1000 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $4.8M$4,792,315 |
Buildings and premises | $32.2M$32,174,535 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 31, 2024 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Burmistrz Miasta Kłobuck | |
| Jan 31, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Burmistrz Miasta Kłobuck |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board consists of one member, the company may be represented by the sole member of the management board independently. If the management board consists of two or more members: a) if a President of the Management Board has been appointed in the company, the company may be represented by: 1. the President of the Management Board independently, or 2. a member of the management board acting jointly with the President of the Management Board, or 3. a commercial proxy acting jointly with the President of the Management Board; b) if no President of the Management Board has been appointed in the company, the company may be represented by: 1. two members of the management board acting jointly or 2. a member of the management board acting jointly with a commercial proxy. The company may also be represented by commercial proxies authorised to act independently or jointly on behalf of the company, in accordance with the statement establishing the commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paul Hartmann Ag | 143,534 | $3,877,201.51 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| JZOS.A. | $41,048,656.33 | jzo.com.pl | ||
| Biovicosp. z o.o. | $32,716,605.20 | biovico.com | ||
| InmedS.A. | $13,860,648.96 | inmed.pl | ||
| Verdentsp. z o.o. | $11,260,945.99 | verdent.pl | ||
| Metrum Cryoflexsp. z o.o. | $10,949,020.49 | metrum.com.pl | ||
| Poldentsp. z o.o. | $9,440,759.21 | poldent.pl | ||
| Corning HtlS.A. | $8,708,960.49 | htl.pl | ||
| Lubelskie Zakłady Farmaceutyczne PolfaS.A. | $7,449,773.98 | polfa.pl | ||
| MargomedS.A. | $6,360,594.28 | margomed.com | ||
| Infimedsp. z o.o. | $5,587,133.78 | infimed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-10-09 | Share capital change (12,033,400.00 PLN → 14,353,400.00 PLN) | |
| 2025-05-09 | Share capital change (5,411,200.00 PLN → 12,033,400.00 PLN) | |
| 2022-11-24 | Address change (Ul. Stefana Żeromskiego 17, 95-200, Pabianice → Ul. Wspólna 3, 42-125, Libidza) | |
| 2022-11-24 | Share capital change (3,205,600.00 PLN → 5,411,200.00 PLN) | |
| 2022-04-01 | Share capital change (1,000,000.00 PLN → 3,205,600.00 PLN) |
FAQ
Last updated: 2026-10-03